FindTrial
Sign In

IL4 regulates NF-?B signaling pathway to inhibit osteoclast differentiation and OPLL, a molecular pathological study

IL4 regulates NF-?B signaling pathway to inhibit osteoclast differentiation and OPLL, a molecular pathological study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063262
Enrollment
Unknown
Registered
2022-09-02
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ossification of the posterior longitudinal ligament

Interventions

case series:None

Sponsors

Huai'an First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Cervical spondylosis with OPLL and non-OPLL; 2. There are surgical indications, no surgical contraindications, and consent to surgical treatment.

Exclusion criteria

Exclusion criteria: Combined with other calcium metabolism-related diseases.

Design outcomes

Primary

MeasureTime frame
Interleukin 4;—

Countries

China

Contacts

Public ContactCheng Zhang

Huai'an First People's Hospital

nightcancer@163.com+86 15861756152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026